Risk communication in consultations about hormone therapy in the menopause: Concordance in risk assessment and framing due to the context

Climacteric

Volumn 9, Issue 5, 2006, Pages 347-354

  Hoffmann, M ^a,d   Hammar, M ^a   Kjellgren, K I ^b   Lindh Astrand L ^a   Ahlner, J ^c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c DEPARTMENT OF FORENSIC GENETICS AND FORENSIC TOXICOLOGY   (Sweden)

^d Ledningsstaben/läkemedelsgruppen Landstinget I Östergö tland ^*  (Sweden)

Author keywords

Communication; Physician patient relations; Professional patient relations; Risk; Risk assessment

Indexed keywords

ADULT; ARTICLE; CLIMACTERIUM; CLINICAL ARTICLE; CONSULTATION; DECISION MAKING; DOCTOR PATIENT RELATION; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SWEDEN;

COMMUNICATION; DECISION MAKING; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS; INTERVIEWS AS TOPIC; MENOPAUSE; MIDDLE AGED; PATIENT PARTICIPATION; PHYSICIAN-PATIENT RELATIONS; REFERRAL AND CONSULTATION; RISK ASSESSMENT; SWEDEN;

EID: 33749006578     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130600870220     Document Type: Article

References (41)

1. Whitney SN, McGuire AL, McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med 2004;140:54-9
2. Edwards A, Elwyn G. Understanding risk and lessons for clinical risk communication about treatment preferences. Qual Health Care 2001;10(Suppl 1):I9-I13
3. Bogardus ST, Jr., Holmboe E, Jekel JF. Perils, pitfalls, and possibilities in talking about medical risk. JAMA 1999;281:1037-41
4. Kjellgren KI, Ahlner J, Dahlöf B, Gill H, Hedner T, Säljö R. Patients' and physicians' assessment of risks associated with hypertension and benefits from treatment. J Cardiovasc Risk 1998;5:161-6
5. Braddock III CH, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. Informed decision making in outpatient practice: Time to get back to basics. JAMA 1999;282:2313-20
6. Fagerberg CR, Kragstrup J, Stovring H, Rasmussen NK. How well do patient and general practitioner agree about the content of consultations? Scand J Prim Health Care 1999;17:149-52
7. Marvel MK, Epstein RM, Flowers K, Beckman HB. Soliciting the patient's agenda: have we improved? JAMA 1999;281:283-7
8. Elwyn G, Edwards A, Wensing M, Hibbs R, Wilkinson C, Grol R. Shared decision making observed in clinical practice: visual displays of communication sequence and patterns. J Eval Clin Pract 2001;7:211-21
9. Griffiths F, Green E, Tsouroufli M. The nature of medical evidence and its inherent uncertainty for the clinical consultation: Qualitative study. Br Med J 2005;330:511.
10. Elwyn G, Edwards A, Mowle S, et al. Measuring the involvement of patients in shared decision-making: a systematic review of instruments. Patient Educ Couns 2001;43:5-22
11. Beck RS, Daughtridge R, Sloane PD. Physician-patient communication in the primary care office: a systematic review. J Am Board Fam Pract 2002;15:25-38
12. Wu WC, Pearlman RA. Consent in medical decision making. J Gen Intern Med 1988;3:9-14
13. Kalet A, Roberts JC, Fletcher R. How do physicians talk with their patients about risks? J Gen Intern Med 1994;9:402-4
14. Hoffmann M, Lindh-Åstrand L, Ahlner J, Hammar M, Kjellgren KI. Hormone replacement therapy in the menopause. Structure and content of risk talk. Maturitas 2005;50:8-18
15. Bjerrum L, Hamm L, Toft B, Munck A, Kragstrup J. Do general practitioner and patient agree about the risk factors for ischaemic heart disease? Scand J Prim Health Care 2002;20:16-21
16. Paling J. Strategies to help patients understand risks. Br Med J 2003;327:745-8
17. Becker MH, Maiman LA. Strategies for enhancing patient compliance. J Community Health 1980;6:113-35
18. Alaszewski A, Horlick-Jones T. How can doctors communicate information about risk more effectively? Br Med J 2003;327:728-31
19. Epstein RM, Alper BS, Quill TE. Communicating evidence for participatory decision making. JAMA 2004;291:2359-66
20. Hoffmann M, Linell P, Lindh-Åstrand L, Kjellgren KI. Risk talk: rhetorical strategies in consultations on hormone replacement therapy. Health, Risk & Society 2003;5:139-54
21. Edwards R, Wiholm B-E, Martinez C. Concepts in risk-benefit assessment: a simple merit analysis of a medicine? Drug Safety 1996;1:1-7
22. Risk: Analysis, perception and management. London: Royal Society, 1992
23. Neil N, Malmfors T, Slovic P. Intuitive toxicology: expert and lay judgments of chemical risks. Toxicol Pathol 1994;22:198-201
24. Slovic P. Intuitive toxicology. II. Expert and lay judgments of chemical risks in Canada. Risk Analysis 1995;15:661-75
25. Asch DA, Hershey JC. Why some health policies don't make sense at the bedside. Ann Intern Med 1995;122:846-50
26. Redelmeier DA, Tversky A. Discrepancy between medical decisions for individual patients and for groups. N Engl J Med 1990;322:1162-4
27. Risk assessment in the federal government: Managing the process. Washington DC: National Research Council, 1983
28. Starr C. Social benefit versus technological risk. Science 1969;165:1232-8
29. Slovic P. Perception of risk. Science 1987;236:280-5
30. Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science 1981;211:453-8
31. Tversky A, Kahneman D. Judgement under uncertainty: heuristics and biases. Science 1974;185:1124-31
32. Ballard K. Understanding risk: women's perceived risk of menopause-related disease and the value they place on preventive hormone replacement therapy. Fam Pract 2002;19:591-5
33. Scheid DC, Coleman MT, Hamm RM. Do perceptions of risk and quality of life affect use of hormone replacement therapy by postmenopausal women? J Am Board Fam Pract 2003;16:270-7
34. Edwards A, Hood K, Matthews E, et al. The effectiveness of one-to-one risk communication interventions in health care: a systematic review. Med Decis Making 2000;20:290-7
35. Walter FM, Britten N. Patients' understanding of risk: a qualitative study of decision-making about the menopause and hormone replacement therapy in general practice. Fam Pract 2002;19:579-86
36. Walter FM, Emery JD, Rogers M, Britten N. Women's views of optimal risk communication and decision making in general practice consultations about the menopause and hormone replacement therapy. Patient Educ Couns 2004;53:121-8
37. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002;288:49-57
38. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33
39. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-27
40. Nilsson JL, Johansson H, Wennberg M. Large differences between prescribed and dispensed medicines could indicate undertreatment. Drug Inform J 1995;29:1243-6
41. O'Connor A, Stacey D, Rovner D, et al. Decision aids for people facing health treatment or screening decisions. The Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD001431. DOI: 10.1002/14651858.CD001431